Comirnaty: Clinical Trials

3 trials of Comirnaty, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Completed 1

Follow Comirnaty: new trials by email Literature Review of Comirnaty trials Research Report on Comirnaty

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1a Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
RQ3013, Comirnaty - COVID-19
Phase 1UnknownWalvax Biotechnology Co., Ltd.1202022-12-012022-11-18
A Phase 1b Trial to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Chimera Vaccine Against COVID-19
RQ3013, Comirnaty - COVID-19
Phase 1UnknownWalvax Biotechnology Co., Ltd.1202022-07-012022-05-31
Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19
MVA-SARS-2-S vaccinations (days 0 & 28), Comirnaty - Covid19
Phase 1CompletedUniversitätsklinikum Hamburg-Eppendorf302020-10-052021-11-05

Conditions studied

COVID-19 (3)

Sponsors

Walvax Biotechnology Co., Ltd. (2)  ·  Universitätsklinikum Hamburg-Eppendorf (1)

Countries

Germany (1)

Top investigators

Lin Yuan (2)  ·  Marylyn M Addo, MD (1)

Results publications

PMID 39749328